Epstein-Barr virus infection as a complication of transplantation of a nerve allograft from a living related donor. Case report

Journal of Neurosurgery

Volumn 106, Issue 5, 2007, Pages 924-928

  Larsen, Mikko ^a   Habermann, Thomas M ^a   Bishop, Allen T ^a   Shin, Alexander Y ^a   Spinner, Robert J ^a  

^a MAYO CLINIC   (United States)

Author keywords

Epstein Barr virus infection; Nerve allograft; Obstetric brachial plexus palsy; Posttransplant lymphoproliferative disorder

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; TACROLIMUS; VIRUS DNA;

ALLOGRAFT; ALLOTRANSPLANTATION; ANAMNESIS; ARTICLE; BIRTH INJURY; BRACHIAL PLEXUS INJURY; CASE REPORT; CLINICAL EXAMINATION; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; FEVER; GRAFT FAILURE; HUMAN; LEUKOCYTOSIS; MALE; NERVE TRANSPLANTATION; NEUTROPENIA; PATIENT MONITORING; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; VIRUS INFECTION;

ARM; BIRTH INJURIES; BRACHIAL PLEXUS; CHILD, PRESCHOOL; EPSTEIN-BARR VIRUS INFECTIONS; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVING DONORS; MALE; NERVE REGENERATION; NERVE TISSUE; NERVE TRANSFER; OPPORTUNISTIC INFECTIONS; REOPERATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 34247842917     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/jns.2007.106.5.924     Document Type: Article

References (33)

1. Atchabahian A, Doolabh VB, Mackinnon SE, Yu S, Hunter DA, Flye MW: Indefinite survival of peripheral nerve allografts after temporary Cyclosporine A immunosuppression. Restor Neurol Neurosci 13:129-139, 1998
2. Atchabahian A, Genden EM, MacKinnon SE, Doolabh VB, Hunter DA: Regeneration through long nerve grafts in the swine model. Microsurgery 18:379-382, 1998
3. Auba C, Hontanilla B, Arcocha J, Gorria O: Peripheral nerve regeneration through allografts compared with autografts in FK506-treated monkeys. J Neurosurg 105:602-609, 2006
4. Bain JR: Peripheral nerve allografting: review of the literature with relevance to composite tissue transplantation. Transplant Proc 30:2762-2767, 1998
5. Brenner MJ, Tung TH, Jensen JN, Mackinnon SE: The spectrum of complications of immunosuppression: is the time right for hand transplantation? J Bone Joint Surg Am 84:1861-1870, 2002
6. Butler PEM: Discussion in Jiang HQ, Wang Y, Hu XB, Li YS, Li JS: Composite tissue allograft transplantation of cephalocervical skin flap and two ears. Plast Reconstr Surg 115:36E-37E, 2005
7. Fabian T, Lohmann K: Nerve transplantation: a father's final gift. J Transpl Coord 9:175-176, 1999
8. Foucher G: Prospects for hand transplantation. Lancet 353: 1286-1287, 1999
9. Fridell JA, Jain A, Reyes J, Biederman R, Green M, Sindhi R, et al: Causes of mortality beyond 1 year after primary pediatric liver transplant under tacrolimus. Transplantation 74:1721-1724, 2002
10. Ganschow R, Schulz T, Meyer T, Broering DC, Burdelski M: Low-dose immunosuppression reduces the incidence of posttransplant lymphoproliferative disease in pediatric liver graft recipients. J Pediatr Gastroenterol Nutr 38:198-203, 2004
11. Ghobrial IM, Habermann TM, Macon WR, Ristow KM, Larson TS, Walker RC, et al: Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases? Transplantation 79: 244-247, 2005
12. Ghobrial IM, Habermann TM, Maurer MJ, Geyer SM, Ristow KM, Larson TS, et al: Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders. J Clin Oncol 23:7574-7582, 2005
13. Grand AG, Myckatyn TM, Mackinnon SE, Hunter DA: Axonal regeneration after cold preservation of nerve allografts and immunosuppression with tacrolimus in mice. J Neurosurg 96: 924-932, 2002
14. Gruber SA, Mancias P, Swinford RD, Prashner HR, Clifton J, Henry MH: Living-donor nerve transplantation for global obstetric brachial plexus palsy. J Reconstr Microsurg 22:245-254, 2006
15. Harris NL, Swerdlow SH, Frizzera G, Knowles DM: Post-transplant lymphoproliferative disorders, in Jaffe ES, Harris NL, Stein H, Vardiman JW (eds): Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001, pp 264-269
16. Hess JR, Brenner MJ, Fox IK, Nichols CM, Myckatyn TM, Hunter DA, et al: Use of cold-preserved allografts seeded with autologous Schwann cells in the treatment of a long-gap peripheral nerve injury. Plast Reconstr Surg 119:246-259, 2007
17. Hontanilla B, Auba C, Arcocha J, Gorria O: Nerve regeneration through nerve autografts and cold preserved allografts using tacrolimus (FK506) in a facial paralysis model: a topographical and neurophysiological study in monkeys. Neurosurgery 58: 768-779, 2006
18. Jenson H, McIntosh K, Pitt J, Husak S, Tan M, Bryson Y, et al: Natural history of primary Epstein-Barr virus infection in children of mothers infected with human immunodeficiency virus type 1. J Infect Dis 179:1395-1404, 1999
19. Klein G, Purtilo D: Summary: symposium on Epstein-Barr virusinduced lymphoproliferative diseases in immunodeficient patients. Cancer Res 41:4302-4304, 1981
20. Kogan-Liberman D, Burroughs M, Emre S, Moscona A, Shneider BL: The role of quantitative Epstein-Barr virus polymerase chain reaction and preemptive immunosuppression reduction in pediatric liver transplantation: a preliminary experience. J Pediatr Gastroenterol Nutr 33:445-449, 2001
21. Mackinnon SE: Nerve allotransplantation following severe tibial nerve injury. Case report. J Neurosurg 84:671-676, 1996
22. Mackinnon SE, Doolabh VB, Novak CB, Trulock EP: Clinical outcome following nerve allograft transplantation. Plast Reconstr Surg 107:1419-1429, 2001
23. Mackinnon SE, Hudson AR: Clinical application of peripheral nerve transplantation. Plast Reconstr Surg 90:695-699, 1992
24. Mackinnon SE, Midha R, Bain J, Hunter D, Wade J: An assessment of regeneration across peripheral nerve allografts in rats receiving short courses of cyclosporin A immunosuppression. Neuroscience 46:585-593, 1992
25. Midha R, Mackinnon SE, Becker LE: The fate of Schwann cells in peripheral nerve allografts. J Neuropathol Exp Neurol 53: 316-322, 1994
26. Paya CV, Fung JJ, Nalesnik MA, Kieff E, Green M, Gores G, et al: Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation 68:1517-1525, 1999
27. Sen SK, Lowe JB III, Brenner MJ, Hunter DA, Mackinnon SE: Assessment of the immune response to dose of nerve allografts. Plast Reconstr Surg 115:823-830, 2005
28. Shapiro R, Nalesnik M, McCauley J, Fedorek S, Jordan ML, Scantlebury VP, et al: Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation 68: 1851-1854, 1999
29. Smets F, Latinne D, Bazin H, Reding R, Otte JB, Buts JP, et al: Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease. Transplantation 73:1603-1610, 2002
30. Smets F, Sokal EM: Epstein-Barr virus-related lymphoproliferation in children after liver transplant: role of immunity, diagnosis, and management. Pediatr Transplant 6:280-287, 2002
31. Strasberg SR, Mackinnon SE, Genden EM, Bain JR, Purcell CM, Hunter DA, et al: Long-segment nerve allograft regeneration in the sheep model: experimental study and review of the literature. J Reconstr Microsurg 12:529-537, 1996
32. Verschuuren EA, Stevens SJ, van Imhoff GW, Middeldorp JM, de Boer C, Koeter G, et al: Treatment of posttransplant lymphoproliferative disease with rituximab: the remission, the relapse, and the complication. Transplantation 73:100-104, 2002
33. Walker RC, Marshall WF, Strickler JG, Wiesner RH, Velosa JA, Habermann TM, et al: Pretransplantation assessment of the risk of lymphoproliferative disorder. Clin Infect Dis 20:1346-1353, 1995